SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection.
Charles O ObonyoVincent O WerePeter WamaeErick M O MuokPublished in: Trials (2023)
Pan-African Clinical Trials Registry PACTR202001919442161 . Retrospectively registered on 6 January 2020.